<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01598649</url>
  </required_header>
  <id_info>
    <org_study_id>LSEP H52-12</org_study_id>
    <nct_id>NCT01598649</nct_id>
  </id_info>
  <brief_title>Intervention With Lupin Protein-enriched Foods in Hypercholesterolemic Subjects</brief_title>
  <official_title>Influence of Intervention With Lupin Protein-enriched Foods on Cardiovascular Risk Factors in Hypercholesterolemic Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Jena</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to elucidate the effects of lupin protein (Lupinus
      angustifolius Boregine) as part of a mixed diet on cardiovascular risk factors and to clarify
      the role of arginine, one of the most abundant amino acids in lupin protein.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is based on a previous finding that a daily dosage of 25 g lupin protein isolate,
      administered as protein drinks, is capable to influence the plasma lipids positively.

      Consequently, the physiological effects of a mixed diet containing 25 g lupin protein isolate
      per day will be investigated compared to 1) a diet containing 25 g of milk protein as well as
      to 2) a diet with 25 g milk protein and additionally the amino acid arginine supplemented
      daily.

      A double-blinded, controlled, randomized cross-over trial will be performed. Altogether 75
      volunteers with hypercholesterolemia will be divided into three groups of 25 subjects each.
      After a run-in period (baseline), the first group will consume foods with lupin protein
      isolate (group A), the second group will receive the same foods with milk protein isolate
      (group B) and the third group will consume the foods with milk protein and 1,6 g arginine per
      day over a period of four weeks. After a wash-out period of six weeks, the diet will be
      crossed within the three groups for a second intervention period of four weeks. After another
      wash-out period, diet will be crossed within the three groups once again.

      Arginine will be provided as capsule (1,6 g per day = four capsules per day) in one of the
      two groups receiving foods with milk protein. In the other groups (receiving foods with lupin
      protein or milk protein only) four placebo capsules will be served, containing mannitol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in cholesterol metabolism</measure>
    <time_frame>After 0, 4, 10, 14, 20, and 24 weeks</time_frame>
    <description>Blood lipids (total cholesterol, LDL cholesterol, HDL cholesterol, cholesterol, triacylglyceroles)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in protein metabolism</measure>
    <time_frame>After 0,4, 10, 14, 20, and 24 weeks</time_frame>
    <description>Plasma: amino acids, total protein, albumin, urea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in body composition (body status)</measure>
    <time_frame>After 0, 4, 10, 14, 20, and 24 weeks</time_frame>
    <description>Bioelectrical impedance analysis, body weight, blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in high-sensitive CRP</measure>
    <time_frame>After 0, 4, 10, 14, 20, and 24 weeks</time_frame>
    <description>Inflammation marker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in parameter of diabetes mellitus</measure>
    <time_frame>After 0, 4, 10, 14, 20, and 24 weeks</time_frame>
    <description>Fasting glucose</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Lupin protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lupin protein isolate (cultivar: Lupinus angustifolius Boregine; incorporated in study products) and placebo capsules with mannitol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Milk protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Milk Protein Isolate (75% sodium caseinate (EM7; DMV international) and 25% whey protein (Megglosat HP; Meggle), incorporated in study products) and Placebo capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Milk protein and arginine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Milk Protein Isoalte (75% sodium caseinate (EM7; DMV international) and 25% whey protein (Megglosat HP; Meggle), incorporated in study products) and 1,6 g Arginin in four caspules per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fabricated foods with lupin protein</intervention_name>
    <description>- Foods containing altogether 25 g lupin protein isolate (bread, roll, sausage, spread)</description>
    <arm_group_label>Lupin protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mannitol</intervention_name>
    <description>- Placebo capsules containing mannitol (four capsules per day)</description>
    <arm_group_label>Lupin protein</arm_group_label>
    <arm_group_label>Milk protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Arginine</intervention_name>
    <description>- Capsules containing arginine (four capsules per day with a total daily dosage of 1,6 g)</description>
    <arm_group_label>Milk protein and arginine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fabricated foods with milk protein</intervention_name>
    <description>Foods containing altogether 25 g milk protein isolate (bread, roll, sausage, spread)</description>
    <arm_group_label>Milk protein</arm_group_label>
    <arm_group_label>Milk protein and arginine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Moderate Hypercholesterolemia (total cholesterol &gt;= 5.2 mmol/L)

          -  Age: 20-80 years

        Exclusion Criteria:

          -  Intake of lipid-lowering pharmaceuticals

          -  Allergy against legumes

          -  Intolerance or allergy against milk

          -  Pregnancy, lactation

          -  Chronic bowel diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Jahreis, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Friedrich Schiller University Jena, Institute of Nutrition, Department of Nutritional Physiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Friedrich Schiller University Jena, Department of Nutritional Physiology</name>
      <address>
        <city>Jena</city>
        <state>Thuringia</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2012</study_first_submitted>
  <study_first_submitted_qc>May 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2012</study_first_posted>
  <last_update_submitted>October 28, 2013</last_update_submitted>
  <last_update_submitted_qc>October 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jena</investigator_affiliation>
    <investigator_full_name>Gerhard Jahreis</investigator_full_name>
    <investigator_title>Prof. Dr. habil.</investigator_title>
  </responsible_party>
  <keyword>Dietary protein</keyword>
  <keyword>Lupin protein</keyword>
  <keyword>Cholesterol metabolism</keyword>
  <keyword>Protein metabolism</keyword>
  <keyword>Hypercholesterolemia</keyword>
  <keyword>Protein-enriched foods</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

